University of Colorado Cancer Center
Playback speed
10 seconds
ASCO® 2023 Insights: "Effect of CBM588 in Combination With Cabozantinib + Nivolumab for Patients With mRCC - A Randomized Clinical Trial"
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Hedyeh Ebrahimi
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Hedyeh Ebrahimi
105 views
June 14, 2023
Comments 0
Login to view comments.
Click here to Login
Videos